|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/08 | |
| A61K 47/26 | |||
| A61K 47/38 | |||
| A61K 9/16 | |||
| A61K 31/55 |
| (11) | Patento numeris | 2961383 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14712793.0 |
| Europos patento paraiškos padavimo data | 2014-02-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-02-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2014/055890 |
| Data | 2014-02-28 |
| (87) | Numeris | WO 2014/133196 |
| Data | 2014-09-04 |
| (30) | Numeris | Data | Šalis |
| 2013041105 | 2013-03-01 | JP |
| (72) |
AKAGI, Akitsuna, JP
SUZUKI, Kai, JP
NAKAMURA, Atsuya, JP
NISHIBAYASHI, Toru, JP
|
| (73) |
Otsuka Pharmaceutical Co., Ltd.,
9, Kanda-Tsukasamachi 2-chome Chiyoda-ku, Tokyo 101-8535,
JP
|
| (54) | SUSPENSION FOR ORAL ADMINISTRATION COMPRISING AMORPHOUS TOLVAPTAN |
| SUSPENSION FOR ORAL ADMINISTRATION COMPRISING AMORPHOUS TOLVAPTAN |